| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/07/1992 | US5128319 Prophylaxis and therapy of acquired immunodeficiency syndrome |
| 07/07/1992 | US5128258 Iron-releasing monokines |
| 07/07/1992 | US5128257 Electroporation apparatus and process |
| 07/07/1992 | US5128254 Cdna encoding the long isoform of the d2 dopamine receptor |
| 07/07/1992 | US5128246 Olfactory, genetic engineering |
| 07/07/1992 | US5128242 Hormone release |
| 07/07/1992 | US5128130 Hybrid Bacillus thuringiensis gene, plasmid and transformed Pseudomonas fluorescens |
| 07/07/1992 | US5128129 Infectious bovine rhinotrachetis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same |
| 07/07/1992 | US5128128 Virus vaccine |
| 07/07/1992 | CA1304888C Immunologically active polypeptides useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of antisporozoite antibodies |
| 07/07/1992 | CA1304887C Purification of recombinant hepatitis b surface antigen |
| 07/07/1992 | CA1304704C Production of interferon gamma |
| 07/07/1992 | CA1304681C Stable biologically active fluorochemical emulsions |
| 07/05/1992 | WO1992012262A1 Dna sequences related to isolated fragile x syndrome |
| 07/05/1992 | WO1992012169A1 Pseudomonas peptide composition and method for producing the same |
| 07/05/1992 | WO1992011874A1 Tumor susceptible non-human animals |
| 07/05/1992 | CA2098827A1 Tumor susceptible non-human animals |
| 07/05/1992 | CA2094938A1 Dna sequences related to isolated fragile x syndrome |
| 07/03/1992 | WO1992012237A1 Fusions of a viral protein and a destructive enzyme |
| 07/02/1992 | DE4041351A1 Test antigen for diagnosis of legionellosis and listeriosis - comprises soluble cell components of Legionella, Listeria or Brochothrix |
| 07/02/1992 | DE4041045A1 Zweiphasen-systeme fuer die produktion und praesentation von fremdantigen in hybriden lebendimpfstoffen Two-phase systems for the production and presentation of foreign antigen in hybrid live vaccines |
| 07/02/1992 | DE4038887A1 Verfahren zur herstellung von kollagenpartikeln und ihre verwendung als wirkstofftraeger A process for the production of collagen particles and their use as wirkstofftraeger |
| 07/01/1992 | EP0493137A1 A method for forming ultra-fine structures |
| 07/01/1992 | EP0492964A2 Cloning and expression of Borrelia lipoproteins |
| 07/01/1992 | EP0492920A1 Chimaeric influenza-HIV vaccine |
| 07/01/1992 | EP0492614A2 Epitheliocyte growth accelerator |
| 07/01/1992 | EP0492560A2 Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of HIV-1, and related peptides |
| 07/01/1992 | EP0492552A1 Anti-IGF-II monoclonal antibody |
| 07/01/1992 | EP0492536A2 Method for the production of pathogen resistant plants |
| 07/01/1992 | EP0492525A2 Babesial protease antigen |
| 07/01/1992 | EP0492500A2 Protecting plasmodium falciparum hybrid proteins, containing partial sequences of malaria antigens HRPII and SERP |
| 07/01/1992 | EP0492448A1 Monoclonal antibodies against human tumor necrosis factor alpha |
| 07/01/1992 | EP0492274A2 An asporogenous strain of bacillus subtilis and its use as a host for the preparation of heterologous products |
| 07/01/1992 | EP0492214A2 Human Interleukin-5 receptor |
| 07/01/1992 | EP0492179A2 Avian growth hormone receptor and binding protein |
| 07/01/1992 | EP0491888A1 Immunotherapeutic compositions for treating and preventing aids, arc and hiv infection |
| 07/01/1992 | EP0491873A1 Therapeutic compositions; methods for treatment of hiv infections |
| 07/01/1992 | EP0491867A1 Hybridoma ct43 producing a monoclonal antibody to a mucin epitope of colorectal cancer. |
| 07/01/1992 | EP0491861A1 Prophylaxis and therapy of acquired immunodeficiency syndrome |
| 07/01/1992 | EP0491859A1 TREPONEMA HYODYSENTERIAE ANTIGENS HAVING A MOLECULAR WEIGHT OF 39kDa AND DNA ENCODING THEREFOR |
| 07/01/1992 | EP0491858A1 Method and useful apparatus for preparing pharmaceutical compositions |
| 07/01/1992 | EP0491849A1 A method for the purification of transforming growth factor (tgf-). |
| 07/01/1992 | EP0491844A1 Peptides including ctl epitopes of hiv proteins and use thereof |
| 07/01/1992 | EP0491828A1 PEPTIDES FROM GTPase-ACTIVATING PROTEIN (GAP), DIAGNOSTIC AND THERAPEUTIC USE THEREOF |
| 07/01/1992 | EP0491743A1 Polygalacturonase gene from erwinia carotovora and its molecular cloning |
| 07/01/1992 | CA2058595A1 Acid-labile linker molecules |
| 06/30/1992 | US5126433 Glycoprotein which can form complex with human immunodeficiency virus envelope glyprotein |
| 06/30/1992 | US5126399 Methods and compositions for the preparation and use of site-directed immunologic reagents |
| 06/30/1992 | US5126327 Oligo- or polypeptide |
| 06/30/1992 | US5126326 Enzyme inhibiting peptide derivatives |
| 06/30/1992 | US5126325 Method for treating thrombocytopenia |
| 06/30/1992 | US5126323 Homogeneous purified k-fgf and compositions containing the same |
| 06/30/1992 | US5126322 Pancreatic secretory tryspin inhibitor and variants thereof produced by a recombinant host therefore and pharmaceutical use thereof |
| 06/30/1992 | US5126264 The RESA and FIRA antigens of plasmodium falciparum |
| 06/30/1992 | US5126257 Antimicrobial proteins, compositions containing same and uses thereof |
| 06/30/1992 | US5126253 Production of monoclonal antibodies |
| 06/30/1992 | US5126252 Production of bovine and porcine growth hormones |
| 06/30/1992 | US5126249 Enzymatic removal of a protein amino-terminal sequence |
| 06/30/1992 | US5126240 Hybridomas and monoclonal paratopic molecules to apolipoprotein a-i |
| 06/30/1992 | US5126148 Produced by human hematopoietic cells |
| 06/30/1992 | US5126134 Pharmaceutically active combination |
| 06/30/1992 | US5126133 Applying insecticidal mixtures containing cells or spores of bacteria or its mutants |
| 06/30/1992 | US5126130 Monoclonal antibodies reactive with specific antigenic sites on human cytomegalovirus glycoprotein a |
| 06/30/1992 | CA1304421C Affinity separating using immobilized flocculating reagents |
| 06/30/1992 | CA1304293C Immunoconjugates and methods for their use in tumor therapy |
| 06/30/1992 | CA1304288C Cell-free t cell antigen receptor and its clinical utilities |
| 06/29/1992 | WO1992012178A1 Protein with human choriogonadotropin inhibitory effect |
| 06/29/1992 | WO1992012177A1 Novel megakaryocyte amplifier and production thereof |
| 06/29/1992 | WO1992012140A1 Peptides ketoamides, ketoacids, and ketoesters |
| 06/29/1992 | CA2098702A1 Peptide ketoamides, ketoacids, and ketoesters |
| 06/29/1992 | CA2075981A1 Protein with human choriogonadotropin inhibitory effect |
| 06/29/1992 | CA2073177A1 Megakaryocyte potentiator and method for producing the same |
| 06/29/1992 | CA2058351A1 Avian growth hormone receptor and binding protein |
| 06/28/1992 | WO1992012171A1 New synthethic peptides with imunomodulating activity and preparation thereof |
| 06/28/1992 | WO1992012168A1 Modified hexa- and heptapeptide anaphylatoxin receptor ligands |
| 06/28/1992 | WO1992011858A1 Hexa- and heptapeptide anaphylatoxin-receptor ligands |
| 06/28/1992 | CA2095360A1 Modified hexa- and heptapeptide anaphylatoxin receptor ligands |
| 06/28/1992 | CA2095359A1 Hexa- and heptapeptide anaphylatoxin receptor ligands |
| 06/28/1992 | CA2076877A1 Synthetic peptides with immunomodulating activity and their preparation |
| 06/28/1992 | CA2058003A1 Human-interleukin-5 receptor |
| 06/25/1992 | WO1992010756A1 Human phospholipase activating protein and methods for diagnosis of rheumatoid arthritis |
| 06/25/1992 | WO1992010755A1 Proteins with changed epitopes and methods for the production thereof |
| 06/25/1992 | WO1992010591A1 Chimeric chains for receptor-associated signal transduction pathways |
| 06/25/1992 | WO1992010587A1 Sequencing of surface immobilized polymers utilizing microfluorescence detection |
| 06/25/1992 | WO1992010583A1 G protein-coupled glutamate receptors |
| 06/25/1992 | WO1992010578A1 Dna expression systems based on alphaviruses |
| 06/25/1992 | WO1992010574A1 Inhibition of human immunodeficiency virus by an adeno-associated virus gene for human cells |
| 06/25/1992 | WO1992010573A1 Methods and compositions for the suppression of neu mediated transformation |
| 06/25/1992 | WO1992010569A1 Sperm cell surface protein ph-20. use in a contraceptive vaccine |
| 06/25/1992 | WO1992010568A1 Dna which codes for neurotrophic activity inhibitor and use thereof |
| 06/25/1992 | WO1992010567A1 Synthetic bioadhesive polypeptide |
| 06/25/1992 | WO1992010565A1 Pituitary trh receptor |
| 06/25/1992 | WO1992010518A1 Purified slit protein and sequence elements thereof |
| 06/25/1992 | WO1992010515A1 Derivates of the human parathormone fragment (1-37) in the amide or ethylamide form as active substance |
| 06/25/1992 | WO1992010514A2 Synthetic antigens for the detection of antibodies to hepatitis c virus |
| 06/25/1992 | WO1992010513A1 Subunit papillomavirus vaccine and peptides for use therein |
| 06/25/1992 | WO1992010512A1 Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs |
| 06/25/1992 | WO1992010511A1 Compounds and compositions which inhibit bone resorption |
| 06/25/1992 | WO1992010510A1 Dithiolano- and dithianoglycin-containing renin-inhibiting peptides, process for producing the same and their use in medicaments |
| 06/25/1992 | WO1992010509A1 Renin-inhibiting peptides of the cyclohexylstatin type, process for producing the same and their use in medicaments |